Is EUDA Health Holdings Limited (EUDA) a Buy, Sell, or Hold?
NASDAQ : EUDA
EUDA Health Holdings Limited
$14.8 USD
-$1.08 (-6.8%)
- Volume
- 2.72K
- Average Volume
- 12.3K
- Market Capitalization
- $27.64M
- P/E Ratio
- -13.86
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $86.00
- Year Low
- $5.26
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.18
Company Overview
NASDAQ
Alfred Lim
Medical - Care Facilities
Healthcare
EUDA
123
SG
USD
Liquidity Metrics
-0.56
0.18
0.18
0.06
0.00
Sales & Valuation
$6.82M
2.35
-6.49
-6.32
-2.35
Profitability
-$1.49
-$2.77M
-40.49%
-39.90%
119.56%
-277.36%
P/E Metrics
-13.86
-0.08
-0.08
Analyst Price Target & Rating
2/5
1 Analysts
%
Financial Health Scores
-44.64
4/9
-$4.8M
$1.72M
$5.98M
-$4.28M
Key Metrics (TTM)
$31.75M
2.70
-8.52
0.18
119.56%
239.94%
-16.06%
-14.73%
10 days
Company Executives
| Name | Title |
|---|---|
| Whye Shin Tay | Interim Chief Financial Officer |
| Alex Lai | Chief Executive Officer of CK Health Plus |
| Alfred Lim | Chief Executive Officer & Executive Director |
| Daniel Tan | Chief Technology Officer |
| Johnson Tang | Managing Director of EUDA Health Malaysia Sdn Bhd |
| Aaron Lim | Operational Director |
Poll Results
No votes yet today — be the first to share your view!
About EUDA Health Holdings Limited (NASDAQ:EUDA) Stock
EUDA Health Limited, established in 2019, is a Singapore-based enterprise dedicated to advancing digital healthcare. It provides an innovative platform facilitating online medical consultations for routine, non-urgent health concerns. This entity functions as a subsidiary of Watermark Developments Limited. ...
2026-07-30 06:00:00
SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today provided important additional details of the integrated cell therapy program to be pursued under its recently announced non-binding Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd ("GO POSB") and Shenzhen Innovation Immunotechnology Co.
2026-07-30 06:00:00
SINGAPORE, July 30, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today provided important additional details of the integrated cell therapy program to be pursued under its recently announced non-binding Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Immunotechnology Co., Ltd. (“SIIT”).
2026-07-28 06:00:00
SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today announced that it has signed a Memorandum of Understanding ("MOU") with GO POSB Organoids Pte Ltd ("GO POSB") and Shenzhen Innovation Immunotechnology Co.
2026-07-28 06:00:00
SINGAPORE, July 28, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) a Singapore-based distributor of third-party provided wellness and non-invasive healthcare products and services in Asia, with a focus on Singapore, Malaysia and China, today announced that it has signed a Memorandum of Understanding (“MOU”) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Immunotechnology Co., Ltd. (“SIIT”) to establish a tri-party collaboration with next-generation therapies derived from induced pluripotent stem cells (“iPSC”).
Phreesia (NYSE:PHR) & EUDA Health (NASDAQ:EUDA) Head-To-Head Review
2026-07-28 01:15:18
EUDA Health (NASDAQ: EUDA - Get Free Report) and Phreesia (NYSE: PHR - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, profitability, valuation, earnings, institutional ownership and risk. Profitability This table compares EUDA Health and Phreesia's
2026-06-01 06:05:00
SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) ("EUDA" or the "Company"), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helixé product line with the launch of the Regenixé iPSC-derived Skin Stem Cell Secretome Mask ("Regenixé Mask"), a beauty product developed by Chemokine Pte Ltd ("Chemokine").
2026-06-01 06:05:00
SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helixé product line with the launch of the Regenixé iPSC-derived Skin Stem Cell Secretome Mask (“Regenixé Mask”), a beauty product developed by Chemokine Pte Ltd (“Chemokine”).
2026-06-01 06:00:00
Singapore, June 01, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" and the "Company"), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, received a written notice (the "MVLS Notice") from Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on April 23, 2026, indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities ("MVLS") of $35 million over the last 32 consecutive business days as required by the Nasdaq Listing Rule 5550(b)(2).
Frequently Asked Questions
-
What is the current EUDA Health Holdings Limited (EUDA) stock price?
-
EUDA Health Holdings Limited(NASDAQ:EUDA) stock price is $14.8 in the last trading session. During the trading session, EUDA stock reached the peak price of $86 while $5.26 was the lowest point it dropped to. The percentage change in EUDA stock occurred in the recent session was --6.8% while the dollar amount for the price change in EUDA stock was -$1.08.
-
EUDA's industry and sector of operation?
-
The NASDAQ listed EUDA is part of Medical - Care Facilities industry that operates in the broader Healthcare sector.
-
Who are the executives of EUDA?
-
Whye Shin Tay | Interim Chief Financial Officer
Alex Lai | Chief Executive Officer of CK Health Plus
Alfred Lim | Chief Executive Officer & Executive Director
Daniel Tan | Chief Technology Officer
Johnson Tang | Managing Director of EUDA Health Malaysia Sdn Bhd -
How many employees does EUDA have?
-
Number of EUDA employees currently stands at 123. EUDA operates from 60 Kaki Bukit Place, Singapore, CE 415979, SG.
-
Link for EUDA official website?
-
Official Website of EUDA is: https://eudahealth.com
-
How do I contact EUDA?
-
EUDA could be contacted at phone #8261 8261 and can also be accessed through its website. EUDA operates from 60 Kaki Bukit Place, Singapore, CE 415979, SG.
-
How many shares of EUDA are traded daily?
-
The average number of EUDA shares traded daily for last 3 months was 12.3K.
-
What is the market cap of EUDA currently?
-
The market value of EUDA currently stands at $27.64M with its latest stock price at $14.8